Urinary Incontinence Devices Market Size, Share and Global Trend By Product (Urethral Inserts, Pessary, Male Slings, Female Slings, Artificial Urinary Sphincters, Electrical Stimulation Devices), By Type (Stress Incontinence, Urge Incontinence, Overflow Incontinence, Mixed Incontinence), By Patient (Male & Female), By End User (Clinics, Hospitals, Ambulatory Surgery Centres, Home Care Settings) and Regional Forecast, 2024-2032
KEY MARKET INSIGHTS
According to the World Health Organization (WHO), urinary incontinence is frequently observed in the geriatric population (60 years and above). Several chronic conditions such as prostate cancer, Parkinson’s disease, arthritis, diabetes mellitus, dementia, stroke, chronic obstructive pulmonary disease (COPD) cause urinary incontinence.
According to Health and Human Services, aged women are highly prone to urinary incontinence due to pregnancy, childbirth, and menopause. Urinary incontinence has adverse consequences on the physiological and psychological health of the patient, and it lowers the quality of life. According to the British Journal of Urology International, the prevalence of urinary incontinence has increased by 22% worldwide from 2008 to 2018, which accounts for about 423 million people.
To gain extensive insights into the market, Request for Customization
The increasing prevalence of Urinary Incontinence is a prominent factor to drive the growth of the Global Urinary Incontinence Market during the forecast period. Moreover, a rise in risk factors associated with urinary incontinence such as diabetes, stroke, dementia is further projected to expand the prevalence of urinary incontinence in forthcoming years.
Certain factors such as the risk of urine leakage due to device failure are expected to hamper the growth of the global urinary incontinence devices market.
Key Players Covered
Some of the major companies that are present in the global urinary incontinence devices market are B. Braun Melsungen AG, Medtronic, Teleflex Incorporated, Ethicon USA, LLC., C. R. Bard, Inc., Boston Scientific Corporation, Coloplast A/S, Atlantic Therapeutics, ZSI, Zephyr Surgical Implants, ConvaTec Group PLC, KCWW, Flexicare Medical Limited, InControl Medical, LLC, Hollister Incorporated and others.
SEGMENTATION
Segmentation of the Global Urinary Incontinence Devices Market | |
By Product | · Urethral Inserts · Pessary · Male Slings · Female Slings · Artificial Urinary Sphincters · Electrical Stimulation Devices · Others |
By Type | · Stress Incontinence · Urge Incontinence · Overflow Incontinence · Mixed Incontinence |
By Patient | · Male · Female |
By End User | · Clinics · Hospitals · Ambulatory Surgery Centres · Home Care Settings |
By Geography | · North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa) |
Among the segmentation, hospitals among the end user segment is expected to hold a major share in the global urinary incontinence devices market owing to the larger patient population treated at hospitals which are suffering from urinary incontinence.
KEY INSIGHTS
- Prevalence of urinary incontinence – for key countries, 2018
- Key industry developments – mergers, acquisitions, and partnerships
- Technological advancements in urinary incontinence devices
- Reimbursement scenario – for key countries
- New product launches and pipeline product analysis
REGIONAL ANALYSIS:
North America is projected to hold a considerable share in the global urinary incontinence devices market owing to the increasing prevalence of urinary incontinence which is highly associated with the prevalence of neurological disorders, prostate cancer, and urinary tract infections. Moreover, growth in certain risk factors such as smoking, obesity, and diabetes are expected to propel the incidence of urinary incontinence, resulting in higher adoption of urinary incontinence devices during the forecast period. Asia Pacific holds considerable potential for growth of the global urinary incontinence devices market owing to the larger patient pool and increasing awareness regarding advanced medical devices.
Key Industry Developments |
· In December 2018, FDA approved first non-invasive urinary incontinence device ‘INNOVO’ for treating patients affected by stress urinary incontinence. · In January 2019, Triple W launched a digitally connected urinary incontinence system which monitors the bladder capacity and notifies about urination time. · In January 2019, Leonhardt's Launchpads launched an advanced system ‘BladderCell’ for treating bladder disorders with the help of bioelectric mode. · In February 2019, Boston Scientific Corporation launched AdVance XP Male Sling System for patients suffering from stress urinary incontinence. |
- Ongoing
- 2023
- 2019-2022
-
Get in Touch with Us
-
US +1 833 909 2966 ( Toll Free )
-
